Discover the MAH policy as your gateway to the world’s fastest-growing medical device market
The transformative Marketing Authorization Holder (MAH) Policy in China opens up a whole new level of opportunities for medical device companies.
Previous to this recent policy, OEMs located outside of China were limited by regulation from entering this market.
This is the fourth guide of the “En Route to Mass Production” series.
The potential in China’s medical device market is in reach like never before.
If you're in a position to lead your company to capitalize on this opportunity, this guide is for you.